- All
- Acute kidney injury
- aHUS
- Alport syndrome
- Anaemia
- Andy Cole Fund
- BK virus
- Blog
- Blood pressure
- Calciphylaxis
- Cancer
- Case study
- Chronic kidney disease
- CMV
- Collaboration and partnerships
- Coronavirus
- Corporate partnership
- cystinosis
- Cystinuria
- Diabetes
- Dialysis
- Focal segmental glomerulosclerosis
- Fundraising
- Health Equalities
- Heart disease
- HUS
- Idiopathic nephrotic syndrome
- IgA nephropathy
- Kidney health
- Kidney rare diseases
- Kidney stones
- Lupus
- Mental health
- Nephrotic syndrome
- NURTuRE
- Paediatric
- Patient Stories
- Podcast
- Policy
- Polycystic kidney disease
- Research
- TAKA
- Transplantation
- Uncategorised
- Volunteering

Can we better predict kidney damage from cancer therapies?
Dr Wen Yi Ding and a team, including Professor Moin Saleem and Professor Gavin Welsh, from the University of Bristol, have been awarded a Translation Accelerator Kidney Award (TAKA) of £90,000 to develop a test that could help identify kidney-damaging cancer drugs earlier, helping make new treatments safer for patients. The promise of new anti-cancer drugs, and the challenge for kidneys New types of cancer treatments called radiopharmaceuticals…

New therapy offers hope for children with genetic kidney disease
In new results, published in Science Translational Medicine, Dr Saif Malik, Dr Jennifer Chandler and Professor David Long at University College London (UCL) Great Ormond Street Institute of Child Health, with funding from Kidney Research UK, have developed a new targeted therapy that could slow the progression of genetic childhood glomerular disease. A childhood kidney disease with no existing treatments…

More adults with kidney disease in Scotland given access to treatment for high potassium levels
More adults in Scotland living with chronic kidney disease (CKD) and persistent high potassium levels may now have access to sodium zirconium cyclosilicate (SZC), following a recommendation by the Scottish Medicines Consortium. SMC accepts treatment for wider use A treatment to reduce persistently high levels of potassium in the blood in adults living with CKD in…

Testing a new treatment for childhood polycystic kidney disease
Dr Jennifer Chandler from University College London Great Ormond Street Institute of Child Health has been awarded a £98,000 PKD research project to test a new treatment for children with autosomal recessive polycystic kidney disease (ARPKD) in human kidney cells. This project forms part of the PKD Partnership, led by Kidney Research UK and the PKD Charity. Understanding childhood polycystic…

Kidney transplant waiting list grows and operations fall – our response to latest NHS transplant figures
New NHS figures out today reveal that the UK organ transplant waiting list has hit a new high, and that the number of people waiting for a kidney transplant continues to go up. But, at the same time, the number of kidney transplant operations taking place is going down. We’re calling for the UK Government…

Could the interaction between BK virus and oxygen unlock a new treatment pathway for kidney transplant patients?
Dr Peter Wing and Dr Matthew Bottomley from the University of Oxford has received a Translation Accelerator Kidney Award (TAKA) of £120,000 to investigate how BK virus is influenced by the kidney’s low-oxygen response in transplant patients and identify new potential treatment targets. Dr Peter Wing and Dr Matthew Bottomley The ongoing challenge of BK virus in kidney transplant patients BK…

How can engineering improve dialysis experience for kidney patients?
Dr Glen Cooper from the University of Manchester has received a Translation Accelerator Kidney Award (TAKA) of £119,000 to develop a realistic training system that helps kidney patients practice haemodialysis needle insertion safely and confidently. Addressing a common fear in dialysis treatment Many patients living with kidney failure often rely on haemodialysis. This is a way of replacing some of the functions of the…



